The healthcare vertical is US-focused, has 35-plus clients and 24,000 employees across 34 locations in five countries
Both companies aim to improve the efficiency and success rate of the current drug discovery process.
Filing for WHO Emergency Use Authorisation this month
Single booster dose at 6 months of NVX-CoV2373 increased wild-type neutralizing antibodies more than 4-fold versus primary vaccination series
Board declares interim dividend of Rs 2 per equity share
By 2022, 150,000 primary health care centres would be in place in rural as well as urban areas
PAT rises to Rs 195.76 crore
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
Innovative solutions and a deep understanding of the market makes this a unique combination
Arch Pharma Labs has filed the application
Subscribe To Our Newsletter & Stay Updated
